Reduced Dosing Frequency Following a Switch to Rix-FP for the Treatment of Hemophilia B: Results from the ATHN 2 Study
Author(s):
Janna Journeycake, Dunlei Cheng, Tammuella Chrisentery-Singleton, Vidhi Desai, Annette von Drygalski, Carol Fedor, Nikki Hirsh, Birju Patel, Leslie J Raffini, Michael Recht, Robert F Sidonio Jr, Michael Wang, Xiang Zhang, Ellis J Neufeld
Publication:
Blood
Date:
November 23, 2021
Topics:
Dosing, Rix-FP, hemophilia B